Inmaculada Gil Rabadán

Inmaculada Gil Rabadán is an accomplished professional with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as the General Manager for Daiichi Sankyo España since April 2008, Inmaculada focuses on maximizing opportunities within the EU strategic framework while adhering to legal and ethical standards. Prior roles include Director of the Virology Business Unit and CNS Business Unit at Bristol Myers Squibb, where Inmaculada successfully led product launches and managed significant HIV portfolios. Previous positions also include Director of Virology Europe at DuPont Pharmaceuticals and various management roles at Roche and Roche Diagnostics Europe, demonstrating a strong background in marketing strategy, product management, and business development. Inmaculada holds an MBA from IESE Business School and has participated in executive leadership training at the University of Oxford.